Evidence map›Paper›PMID 32158479›Full record

ReviewDrugs in context2019

Motion sickness: an overview.

Alexander Kc Leung, Kam Lun Hon

Open access · goldAbstract readReview
In one paragraph

Review in Drugs in context, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Antihistamines for motion sickness.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The gut feeling in motion sickness.Communications biology · 2025
    Review
  9. Article
  10. Ear, nose and throat disorders and international travel.Tropical diseases, travel medicine and vaccines · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Development of a new immersive virtual reality (VR) headset-based dexterity training for patients with multiple sclerosis: Clinical and technical aspects.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  19. Evaluating proxies for motion sickness in rodent.IBRO neuroscience reports · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Alexander Kc LeungDepartment of Pediatrics, The University of Calgary, Alberta Children's Hospital, Calgary, Alberta, Canada.
Kam Lun HonDepartment of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong.
Chinese University of Hong Kong · CNUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMotion sickness is a common phenomenon that affects almost everybody at some point in their lifetime. Clinicians should be familiar with the proper management of this condition.

objectiveTo provide an update on the current understanding of the pathophysiology and management of motion sickness.

methodsA PubMed search was performed with Clinical Queries using the key term 'motion sickness.' The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews. The search was restricted to English literature. The information retrieved from the earlier search was used in the compilation of the present article.

resultsMotion sickness is typically triggered by low-frequency vertical, lateral, angular, rotary motion, or virtual stimulator motion, to which an individual has not adapted.

conclusionIn most cases, motion sickness can be prevented by behavioral and environmental modifications (avoidance, habituation, and minimization of motion stimuli). Pharmacotherapy should be considered in the prevention and/or treatment of more severe motion sickness and for patients who do not respond to conservative measures. Medications are most effective when combined with behavioral and environmental modifications. Drugs that are effective in the prophylaxis and/or treatment of motion sickness include anticholinergic agents and antihistamines.

Indexed as

antihistaminesnauseaneural mismatchscopolaminesensory conflictsympathomimeticsvomiting

Identifiers

PMID32158479
PMCPMC7048153
OpenAlexW2999901333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.